已收盤 11-06 16:00:00 美东时间
+0.100
+1.03%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从50美元升至51美元;HC Wainwright & Co.:上调伊诺维奥制药评级至"买入",目标价5美元
11-03 18:20
11月3日,SunCoke Energy(SXC)收跌1.24%,报11.19美元,成交额1716.97万美元,市值9.5亿美元。 行情数据 • 开盘价:11...
11-03 06:45
今日重点评级关注:BTIG:维持Cullinan Therapeutics"买入"评级,目标价从40美元升至41美元;Rosenblatt:维持SK海力士"买入"评级,目标价从320美元升至400美元
10-29 12:30
StoneX analyst Nathan P. Martin maintains SunCoke Energy (NYSE:SXC) with a Buy and raises the price target from $10 to $12.
10-28 22:38
U.S. stocks were mixed, with the Dow Jones falling around 0.1% on Tuesday. Shares of Pentair PLC (NYSE:PNR) rose sharply after the company reported better-than-expected third-quarter financial results and raised its FY26 sales guidance above estimates. Pentair posted adjusted earnings of $1.18 per s...
10-27 22:11
SunCoke Energy shares are trading higher after the company reported better-than-expected Q3 financial results.
10-27 20:51
SunCoke Energy 2026财年第三季度营收为4.859亿美元,同比下降0.2%;稀释后每股收益(EPS)由上年同期的0.26美元小幅降至0.25美元。调整后EBITDA增长30.1%至7690万美元,主要得益于工业服务业务受益于多计入一个月的Phoenix业绩以及更高的码头吞吐量;与此同时,尽管销量有所下降,国内焦炭业务仍受益于销售组合优化及有利的炼焦成焦率。营业利润增至4060万美元,但由于失去了上年同期的税收抵免,净利润与上年同期持平。公司目前预计全年调整后EBITDA将略高于2.65亿美元。
10-27 11:16
SunCoke Energy’s Q3 2026 revenue was $485.9 million, down 0.2% year over year, while diluted EPS eased to $0.25 from $0.26. Adjusted EBITDA increased 30.1% to $76.9 million as Industrial Services benefited from an additional month of Phoenix results and higher terminal volumes, while Domestic Coke gained from sales mix and favorable coal-to-coke yields despite lower volume. Operating income rose to $40.6 million, but the loss of prior-year tax cr
10-27 11:14
10月27日,SunCoke Energy(SXC)收跌2%,报9.81美元,成交额782.09万美元,市值8.33亿美元。 行情数据 • 开盘价:10.04美...
10-27 05:50
10月24日,SunCoke Energy(SXC)收涨3.09%,报10.01美元,成交额815.64万美元,市值8.5亿美元。 行情数据 • 开盘价:9....
10-24 05:52